Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rep. Dingell oversight of CLIA

This article was originally published in The Gray Sheet

Executive Summary

Staffers from Rep. John Dingell's (D-Mich.) House Energy and Commerce oversight subcommittee plan to meet with Bruce Vladeck after he is confirmed as Health Care Financing Administration chief to discuss their concerns with implementation of the Clinical Laboratory Improvement Amendments of 1988. Concerns include FDA delays in reviewing quality control labeling and assigning complexity categorizations for tests and the slow pace of third-party accreditation by HCFA. Vladeck was nominated to lead HCFA on March 5 ("The Gray Sheet" March 8, p. 25).
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT000419

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel